Citation Impact
Citing Papers
TRP channel activation by reversible covalent modification
2006 StandoutNobel
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
2010 Standout
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
2010 StandoutScience
Piezo1 and Piezo2 Are Essential Components of Distinct Mechanically Activated Cation Channels
2010 StandoutScienceNobel
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
2013 StandoutNobel
Structure of the human TRPM4 ion channel in a lipid nanodisc
2017 StandoutScienceNobel
Cytoplasmic ankyrin repeats of transient receptor potential A1 (TRPA1) dictate sensitivity to thermal and chemical stimuli
2011 StandoutNobel
Strategy for Dual-Analyte Luciferin Imaging: In Vivo Bioluminescence Detection of Hydrogen Peroxide and Caspase Activity in a Murine Model of Acute Inflammation
2013 StandoutNobel
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1
2007 StandoutNobel
Ciliary Polycystin-2 Is a Mechanosensitive Calcium Channel Involved in Nitric Oxide Signaling Cascades
2009
Receptor for Advanced Glycation End Products Expression on T Cells Contributes to Antigen-Specific Cellular Expansion In Vivo
2007
ANKTM1, a TRP-like Channel Expressed in Nociceptive Neurons, Is Activated by Cold Temperatures
2003 StandoutNobel
Treatment of anabolic–androgenic steroid dependence: Emerging evidence and its implications
2010
Mechanism of action of vitamin C in sepsis: Ascorbate modulates redox signaling in endothelium
2009
International Union of Pharmacology. XLIX. Nomenclature and Structure-Function Relationships of Transient Receptor Potential Channels
2005 StandoutNobel
Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway
2004
Comparison of Pkd1-targeted mutants reveals that loss of polycystin-1 causes cystogenesis and bone defects
2001
The risk of renal impairment in hormone‐refractory prostate cancer patients with bone metastases treated with zoledronic acid
2007
Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines
2007 StandoutNatureNobel
The Effect of Oral Sodium Phosphate Drug Products on Renal Function in Adults Undergoing Bowel Endoscopy
2008
Molecular Understanding and Modern Application of Traditional Medicines: Triumphs and Trials
2007 Standout
The biology of RAGE and its ligands: Uncovering mechanisms at the heart of diabetes and its complications
2007
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown
2018 StandoutNobel
Apparent renal disease due to elevated creatinine levels associated with the use of boldenone
2010
The rediscovery of uromodulin (Tamm–Horsfall protein): from tubulointerstitial nephropathy to chronic kidney disease
2011
Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study
2009
Transient receptor potential channelopathies
2010
Polycystin-1 expression in PKD1, early-onset PKD1, and TSC2/PKD1 cystic tissue
1999
Mouse Models of Diabetic Nephropathy
2004
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
2008
Polycystic kidney disease
2018
A Bivalent Tarantula Toxin Activates the Capsaicin Receptor, TRPV1, by Targeting the Outer Pore Domain
2010 StandoutNobel
Acute phosphate nephropathy
2008
Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells
2003 Standout
International Union of Basic and Clinical Pharmacology. LXXVI. Current Progress in the Mammalian TRP Ion Channel Family
2010
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Acute Renal Failure Associated with Tenofovir Treatment in a Patient with Acquired Immunodeficiency Syndrome
2003
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Endothelial Nitric Oxide Synthase Deficiency Produces Accelerated Nephropathy in Diabetic Mice
2006
Ganglion-specific splicing of TRPV1 underlies infrared sensation in vampire bats
2011 StandoutNatureNobel
Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy
2005
Treatment of hepatitis C-virus-related glomerulonephritis
2006
Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus
2004
Polycystin-2 Is a Novel Cation Channel Implicated in Defective Intracellular Ca2+ Homeostasis in Polycystic Kidney Disease
2001
Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice
2001
Inhibiting eukaryotic transcription. Which compound to choose? How to evaluate its activity?
2011 Standout
Epidemiology, Trends, and Morbidities of Obesity and the Metabolic Syndrome
2006
A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function
2006 StandoutNature
Neurodegeneration and Inflammation
2008
TRP channels as cellular sensors
2003 StandoutNature
A New Perspective on Therapeutic Inhibition of Advanced Glycation in Diabetic Microvascular Complications: Common Downstream Endpoints Achieved Through Disparate Therapeutic Approaches?
2009
A Cell-Penetrating Scorpion Toxin Enables Mode-Specific Modulation of TRPA1 and Pain
2019 StandoutNobel
The Ion Channel Polycystin-2 Is Required for Left-Right Axis Determination in Mice
2002
Transport Function of the Naturally Occurring Pathogenic Polycystin-2 Mutant, R742X
2001
RAGE-Induced Cytosolic ROS Promote Mitochondrial Superoxide Generation in Diabetes
2009
The genetics and physiology of polycystic kidney disease
2001
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Coordinate Expression of the Autosomal Dominant Polycystic Kidney Disease Proteins, Polycystin-2 And Polycystin-1, in Normal and Cystic Tissue
1999
Transgenic and knockout mice to study the renin-angiotensin system and other interacting vasoactive pathways
2000
From endoplasmic-reticulum stress to the inflammatory response
2008 StandoutNature
The receptors and cells for mammalian taste
2006 StandoutNature
Constitutive Activation of G-proteins by Polycystin-1 Is Antagonized by Polycystin-2
2002
Structure of the TRPV1 ion channel determined by electron cryo-microscopy
2013 StandoutNatureNobel
Polycystin
2001
Hepatitis C and renal disease: an update
2003
Extrarenal manifestations of autosomal dominant polycystic kidney disease
1999
EMT: 2016
2016 Standout
Polycystin-2 is an intracellular calcium release channel
2002
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
Biopsy-Proven Acute Interstitial Nephritis, 1993-2011: A Case Series
2014
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes
2004
Blockade of Receptor for Advanced Glycation End-Products Restores Effective Wound Healing in Diabetic Mice
2001
Origin and physiological roles of inflammation
2008 StandoutNature
Noxious Cold Ion Channel TRPA1 Is Activated by Pungent Compounds and Bradykinin
2004 StandoutNobel
Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes
2011
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Ciliar functions in the nephron
2009
Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1
2004 StandoutNatureNobel
Modulation of Soluble Receptor for Advanced Glycation End Products by Angiotensin-Converting Enzyme-1 Inhibition in Diabetic Nephropathy
2005
Two members of the TRPP family of ion channels, Pkd1l3 and Pkd2l1 , are co‐expressed in a subset of taste receptor cells
2006
Spider toxins activate the capsaicin receptor to produce inflammatory pain
2006 StandoutNatureNobel
Identification and Characterization of a Novel Polycystin Family Member, Polycystin-L2, in Mouse and Human: Sequence, Expression, Alternative Splicing, and Chromosomal Localization
2000
Illicit use of androgens and other hormones
2012
TRPA1 Mediates the Inflammatory Actions of Environmental Irritants and Proalgesic Agents
2006 StandoutNobel
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Transient Receptor Potential Cation Channels in Disease
2007 Standout
The N-terminal Extracellular Domain Is Required for Polycystin-1-dependent Channel Activity
2004
The Structure of the Polycystic Kidney Disease Channel PKD2 in Lipid Nanodiscs
2016
Mouse Models of Diabetic Nephropathy
2009 Nobel
Angiogenesis as a therapeutic target
2005 StandoutNature
Recurrent glomerulonephritis following renal transplantation: an update
2003
Adeno-Associated Virus–Mediated CTLA4Ig Gene Transfer Protects MHC-Mismatched Renal Allografts from Chronic Rejection
2006
Liquid chromatography-based determination of urinary free and total N(epsilon)-(carboxymethyl)lysine excretion in normal and diabetic subjects
2003
Polaris, a protein disrupted inorpkmutant mice, is required for assembly of renal cilium
2002
Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes
2008
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Race, APOL1 Risk, and eGFR Decline in the General Population
2016
Long-Term Renal Effects of a Neutralizing RAGE Antibody in Obese Type 2 Diabetic Mice
2004
Alternative splicing of the murine receptor for advanced glycation end‐products (RAGE) gene
2009
Advanced Glycation End Product Interventions Reduce Diabetes-Accelerated Atherosclerosis
2004
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
2015 StandoutNobel
Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene
2001 StandoutNobel
The TRP Superfamily of Cation Channels
2005
The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins
2003
American Society of Clinical Oncology 2003 Update on the Role of Bisphosphonates and Bone Health Issues in Women With Breast Cancer
2003
Olfactory neurons expressing transient receptor potential channel M5 (TRPM5) are involved in sensing semiochemicals
2007 StandoutNobel
Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes
2008
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
2005 Standout
Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene
2001
Identification, classification, and expression of RAGE gene splice variants
2007
Physiology, Phylogeny, and Functions of the TRP Superfamily of Cation Channels
2001
Polycystin 1 is required for the structural integrity of blood vessels
2000
From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines
2004
Higher Plasma Soluble Receptor for Advanced Glycation End Products (sRAGE) Levels Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes
2010
A genetically clamped renin transgene for the induction of hypertension
2002 StandoutNobel
Piezo1, a mechanically activated ion channel, is required for vascular development in mice
2014 StandoutNobel
Physiology, Phylogeny, and Functions of the TRP Superfamily of Cation Channels
2001
Inhibition of NADPH Oxidase Prevents Advanced Glycation End Product–Mediated Damage in Diabetic Nephropathy Through a Protein Kinase C-α–Dependent Pathway
2007
Receptor for Advanced Glycation End Products Mediates Inflammation and Enhanced Expression of Tissue Factor in Vasculature of Diabetic Apolipoprotein E–Null Mice
2001
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Two amino acid residues determine 2-APB sensitivity of the ion channels TRPV3 and TRPV4
2009 StandoutNobel
RAGE Control of Diabetic Nephropathy in a Mouse Model
2006
Mechanisms of Diabetic Complications
2013 Standout
AN INTRODUCTION TO TRP CHANNELS
2005 Standout
Recent insights into diabetic renal injury from thedb/dbmouse model of type 2 diabetic nephropathy
2010
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
Emerging Targets in Photopharmacology
2016 StandoutNobel
Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response
2004 Standout
Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy
2009
A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.
2006
Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells
2004
Polycystin channels and kidney disease
2001
Glycation and Carboxymethyllysine Levels in Skin Collagen Predict the Risk of Future 10-Year Progression of Diabetic Retinopathy and Nephropathy in the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications Participants With Type 1 Diabetes
2005
Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer
2005
Works of Glen S. Markowitz being referenced
Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease
2007
RAGE Drives the Development of Glomerulosclerosis and Implicates Podocyte Activation in the Pathogenesis of Diabetic Nephropathy
2003
A Molecular Profile of Focal Segmental Glomerulosclerosis from Formalin-Fixed, Paraffin-Embedded Tissue
2010
Development of Focal Segmental Glomerulosclerosis after Anabolic Steroid Abuse
2009
Toxic acute tubular necrosis following treatment with zoledronate (Zometa)
2003
Drug-induced acute interstitial nephritis
2010
Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features
2003
Nephrotic syndrome after treatment with pamidronate
2002
Proliferative Glomerulonephritis with Monoclonal IgG Deposits
2009
Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1
2014
Uromodulin storage disease
2007
The pathogenesis of autosomal dominant polycystic kidney disease: an update
2000
Expression of Advanced Glycation End Products and Their Cellular Receptor RAGE in Diabetic Nephropathy and Nondiabetic Renal Disease
2000
Secondary oxalosis due to excess vitamin C intake
2006
Dysproteinemia, proteinuria, and glomerulonephritis
2006
Mycophenolate Mofetil for the Treatment of Interstitial Nephritis
2006
Proliferative glomerulonephritis with monoclonal IgG deposits: A distinct entity mimicking immune-complex glomerulonephritis
2003
Acute Phosphate Nephropathy following Oral Sodium Phosphate Bowel Purgative
2005
Renal Monoclonal Immunoglobulin Deposition Disease
2001
Obesity-related glomerulopathy: An emerging epidemic
2001
Angiotensin converting enzyme inhibition in chronic allograft nephropathy
2002
IgG1λ light and heavy chain renal amyloidosis
2006
Acute phosphate nephropathy
2009
Cardiac defects and renal failure in mice with targeted mutations in Pkd2
2000
Somatic Inactivation of Pkd2 Results in Polycystic Kidney Disease
1998
Hepatitis C Virus-Associated Glomerular Disease in Patients with Human Immunodeficiency Virus Coinfection
1999
Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing
2004
Crystalline Nephropathies
2012
Collapsing Focal Segmental Glomerulosclerosis Following Treatment with High-Dose Pamidronate
2001
Adefovir nephrotoxicity: Possible role of mitochondrial DNA depletion
2001
Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy.
1998
Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients.
2001
Polycystin-2 expression is developmentally regulated
1999